01 Tablets
01 Tablets
Professor
Department of Pharmacy, JU
Email: muhsin_ju@yahoo.com
Contact: +8801866 489 828
Outline
• Tablets – Definition, Properties, Advantages &
Disadvantages
• Tablet Formulation/Tablet Ingredients
• Different types of tablet: brief introduction,
merits/demerits, uses
• Tablet compression: Tablet machine components,
stages of tablet compression, physics of tablet
making (compaction, compression and
consolidation), Different methods of tablet
compression (direct compression, dry granulation
and wet granulation)
• Flow Characteristics of Granules: importance of
flowability, Factors affecting granule/powder flow,
bulk density —definition and estimation,
assessment of flowability
• Processing problems of tablet making
• Evaluation of tablets
Tablets – Definition, Advantages &
Disadvantages
Definition:
• Tablets may be defined as solid dosage forms
containing drug substances with/without
excipients prepared by compression or molding.
• Tablets are mostly intended for oral
administration.
Advantages:
1. Are in unit dosage form and offer greatest dose
precision and least content variation (among all
oral dosage forms).
2. Lowest cost (of all oral forms)
3. Lightest and most compact (of all oral forms).
4. Easiest and cheapest (of all oral forms) to pack,
ship and dispense (among all oral forms).
5. Easiest to swallow with least tendency for hang-
up.
6. Can be designed in some special release forms
Continued…
Disadvantages:
1. Some drugs resist compression into dense
compacts due to their amorphous nature or
flocculent, low-density character.
2. Not suitable for drugs with poor solubility, poor
absorption properties or instability in GI tract.
3. Drugs with offending taste/odour or sensitive to
oxygen/moisture may require
encapsulation/coating before/after compression.
In such cases, capsules may offer the best and
lowest cost approach.
4. Some drugs irritate or may otherwise harm GI
mucosa.
5. May be difficult to swallow for children or elderly
patients.
Assignment: Give general advantages and
Disadvantages of (a) Solid dosage forms (b)
oral dosage forms.
Tablet Ingredients
Tablet formulation = Drug(s) (active ingredient(s)) + Excipients
(Additives)
Various Excipients Used in Tablet formulation:
• Diluents/Fillers/Bulking agents
• Binders and Adhesives
• Disintegrants
• Lubricants, Antiahherents and Glidants
• Colouring, Flavouring and Sweetening agents
Diluents
• Diluents are used to make up the required bulk of the tablet when the
drug dosage itself is not adequate to produce this bulk.
• Secondary reasons: to impart other properties such as improved
cohesion, direct compression or improved flow.
Ideal characteristics of a diluent:
i) Be inert and biocompatible.
ii) Cheap and available.
iii) Be non-hygroscopic.
iv) Should not affect the bioavailability of the drug.
v) Be stable alone and in combination with drugs.
vi) Be free from unacceptable microbiologic load.
vii) Have an acceptable taste.
viii) Be colour compatible.
ix) Not contraindicated by themselves (eg, sucrose) or because of a
component (eg, Na) in any segment of population.
x) Be acceptable to regulatory bodies.
Some commonly used diluents: ???
Continued…
Binders & Adhesives:
• These materials are added to drug-filler mixture either dry or in
solution form (solution binder) to promote adhesion of particles in
order (a) to form granules during wet granulation or (b) to form
cohesive compacts for directly compressed tablets.
• Binders ensure required mechanical strength of granules and final
tablets.
• They are added to the formulation at a relatively low concentration
(typically 2-10% by weight).
• Solution binders are generally considered the most effective and is
the most common way of incorporating a binder into granules.
Some commonly used binders: ???
Disintegrants:
• These agents are added to most tablet formulations to facilitate
breaking or disintegration of the tablet in contact with water in the
GIT.
• Disintegrants may be added prior to or after the granulation
process.
• Disintegrants may function by drawing water into the tablet,
swelling and causing the tablet to burst apart.
• Disintegration of the tablet may be critical to the subsequent
dissolution of the drug and in turn attainment of satisfactory drug
Continued…
Dental Cones
• Relatively minor tablets designed to be placed in the empty socket
remaining following tooth extraction.
• Usual purpose: to prevent bacterial proliferation (by an antibacterial) or
stop/ reduce bleeding (by an astringent or coagulant).
• Should be designed to dissolve or erode slowly in the presence of small
volume of serum or fluid over 20- to 40-min period.
• Usual vehicles: sodium bicarbonate, sodium chloride or an amino acid;
components that may promote bacterial proliferation should be
avoided.
Continued…
Tablets Administered by Other Routes:
Implantation Tablets
• Implantation or depot tablets are designed for subcutaneous implantation
to provide prolonged drug effects (ranging from one month to a year).
• Usually small, cylindric or rosette-shaped in form and typically not more
than 8 mm in length.
• Administered by a special injector (for rod-shaped tablets) or surgically (for
other shapes)
• Primary application: administration of growth hormones to food-producing
animals (the ear of the animal is typically used Why?)
Has got little use in humans because of two major safety considerations
involved What are they?
• Implantation tablets have largely been replaced by other dosage forms,
such as silicone tubes filled with drug or drug-loaded biodegradable
polymers.
Vaginal Tablets
• Vaginal tablets or inserts are designed to undergo slow dissolution and drug
release in the vaginal cavity.
• Typically, ovoid or pear-shaped to facilitate retention in the vagina.
Administered in the upper region of the vaginal tract with some type of
plastic tube inserter.
• Used to release antibacterial agents, antiseptics or astringents for treating
vaginal infections or possibly to release steroids for systemic absorption.
• Often buffered to impart a pH favourable to the action of a given antiseptic
agent.
Continued…
Tablets Used to Prepare Solutions
Effervescent Tablets:
• Designed to produce a solution rapidly with simultaneous CO2 release.
• Typically prepared by compressing the active ingredient(s) with mixtures of organic
acids (eg, citric or tartaric acid) and sodium bicarbonate.
• These agents undergo a rapid reaction (within 1 min or less) in water producing
CO2 to give a pleasantly flavoured carbonated drink.
• Examples: Saline cathartics, Aspirin (commonest use)
• Advantages:
Provides a means for extemporaneous preparation of a solution containing
accurate dose.
Additionally for aspirin: Higher pH of the solution enhance gastric absorption,
Less irritation to gastric mucosa.
• Disadvantage: Unstable (extremely sensitive to moisture) and require special
packaging to protect from moisture.
Dispensing Tablets (DT):
• Intended to produce a solution of a given drug concentration.
• Commonly incorporated materials: silver proteinate, bichloride of mercury,
merbromin and quaternary ammonium compounds.
• All the components must be soluble; the excipients must not produce harmful
effect in the intended application.
• May contain components to provide buffering or isotonicity if the solution is
intended for application to mucous membrane or wound.
• Disadvantages:
Unavailability of appropriate water on a routine basis for producing sterile
solutions (so, less commonly used than formerly).
Danger of serious toxic effects if swallowed mistakenly (if the ingredients are
Continued…
Hypodermic Tablets (HT):
• Consist of one or more drugs with other readily water-soluble
ingredients and are intended to be added to sterile water or water for
injection.
• Advantage: A convenient method for preparing multitude of parenteral
preparations extemporaneously (once widely used).
• Disadvantage: Likelihood of administering a non-sterile solution (so,
little used today).
Mechanical
Continued…
Assessment of Flowability
(a) Angle of Repose ()
(b) Carr’s index/ Compressibility index (CI) and Hausner ratio (HR)
(c) Hopper flow rate
Angle of Repose ()
• When a granular material is poured onto a horizontal surface, it
forms a conical pile. The maximum angle possible between a
loosely piled conical heap of powder and the horizontal plane is
known as the angle of repose ().
• It is a measurement of the frictional and cohesive forces.
frictional and cohesive forces resistance to flow angle of
repose
• 30 free-flowing; 40 poorly flowing
Methods of measurement:
a)Fixed height cone method
Static angle
b)Fixed base cone method
of repose
c)Tilting box method
d)Revolving cylinder/rotating drum
method
(Dynamic or kincetic
1 H where angle
H: of repose)
height of cone
tan
R R: radius of cone
Continued…
Carr’s Index or Compressibility Index (CI) and
Hausner Ratio (HR)
t u CI flow
CI 100
t CI > 20% poor flow
t HR < 1.25
HR
u free flowing
HR > 1.4 poor flow
Hopper Flow Rate
• Monitor continually the flow of material out of conical hopper
onto a recording balance device.
Cause Remedy
• Engraving / • Design lettering as large as possible
Embossing on • Reformulate the tablet to a larger size
punch tips • Chromium plating of the punch face
• Adding colloidal silica to the formulation (as a polishing agent)
• Additional binder or change in binder (→ less adherent granulation)
• Low-melting-point • Dilute the active ingredient with additional higher-melting-point
active ingredient/ materials and consequent increase in tablet size
excipients eg, stearic • Reduce low-melting-point lubricants/
acid/PEG ) Substitute with higher-melting-point replacements
• Refrigeration of the granulation and tablet press
• High moisture level • Further drying of granulation
Mottling:
Unequal distribution of color on a tablet (with light and dark areas in an otherwise
uniform surface).
Cause Remedy
• Difference in drug and excipient color Use colorant/dye
• Colored degradation product of the drug
Causes Remedy
(Factors affecting die filling)
Granule Size and Size Distribution Smaller granule size
Granule size:
Large granules for a small die High percentage
weight variation with the difference of just a few
granules
Granule size distribution:
Narrow size distribution
Wide size distribution Small granules fill in the
gaps between large granules in the die Same
apparent volume, but different weight of fill
Larger weight variation
Poor flow
Poor granulation flow from Hopper Granulation
· Add/ increase glidant, eg talcum,
moves spasmodically through the feed frame
colloidal silica
Some dies are incompletely filled · Use induced die feeders
Machine speed in excess of the granulation’s
flow capabilities dies are not filled properly
Poor flow out of hopper due to arching/ bridging · Attach vibrators to hopper sides
or rat holing
Poor flow due to poor hopper design · Take corresponding measure
Surges of excessive flow · Restrict flow out of the hopper
· Specially designed feed frame
Causes Remedy
(Factors affecting die filling)
Poor Mixing: Take corresponding measure
Inadequate mixing of glidants and lubricants
Unsatisfactory granulation flow from the
hopper into the die
Punch Variation Difference in die fill Need a good punch and die
control program
Hardness Variation
· Hardness depends on the weight of material and the space between
the upper and lower punches at the moment of compression.
· So, hardness variation comes from the same causes as weight
variation, viz.:
Differences in die fill
Variation in the distance between punches
Double Impression
Cause:Engraving in the lower or upper punch with possible rotation of
the lower punch when it freely falls down or of the upper punch between
pre-compression and final compression (if the machine uses double
compression)
EVALUATION OF TABLET
Quantitative evaluations of tablet’s physical, chemical and
bioavailability properties are essential for
a) Designing tablets
b) Monitoring tablet’s production quality
General • Thickness
Appearance • Identification
markings
Evaluatio • Organoleptic
properties
n of • Weight variation
• Hardness &
& Friability
Content uniformity
Tablets Drug content • Disintegration
& Release • Dissolution
GENERAL APPEARANCE
The general appearance of a table, its visual identity and
overall elegance is essential for:
• consumer acceptance
• control of lot-to-lot uniformity and general tablet-to-tablet
uniformity &
• monitoring trouble-free manufacturing.
Continued…
Thickness
Pharmaceutical implications:
• Thickness variation can affect:
(a) Consumer acceptance, (b) Unit dose packaging & (c) Fill
level in
a container
• The thickness variation should be controlled within 5% of a
standard value.
Measurement techniques
Micromete Slide
Continued…
Identification Markings
• The identification markings placed on the tablet should be
clearly legible and elegant.
• These are placed in form of: (a) embossing, (b) engraving or
(c) printing.
• Usually include: (a) the company name or symbol, (b) a
product code, (c) the product name or (d) the potency.
Organoleptic Properties
Colour:
Pharmaceutical importance:
• Colour provides a means of rapid identification and aesthetic
elegance for consumer acceptance.
• Non-uniformity of colour (mottling) reduces aesthetic appeal
and may give the consumer an impression of non-uniformity
of content and general poor quality.
Assessment:
(a) visually against a standard (b) instrumentally by
reflectance spectrophotometry, tristimulus colorimetry or
microreflectance photometry.
Limitation of visual comparison: lack of precision and
subjective variation.
Odour
Continued…
Pharmaceutical importance
• Odour may be indicative of a stability problem (eg, odour of acetic
acid in degrading aspirin tablets).
• In some cases, the odour present may be the characteristic of the
drug, excipients or the dosage form.
Taste
Pharmaceutical importance
Important in consumer acceptance of chewable tablets.
Assessment:
• Many companies utilize taste panels to judge the preference of
different flavours and flavour level.
• However, due to subjectiveness of taste preference, the control of
taste in the production of chewable tablets is often simply the
presence or absence of a specified taste.
Surface characteristics:
• The level of surface flaws such as chips, cracks, foreign
contaminants (eg, hair, oil drops, and dirt), surface texture
(smooth vs. rough) and appearance (shiny vs dull) may have a
zero-defect specification.
Assessment:
• Visual inspection. Subjective in nature.
• Electronic devices (in development) hold promise for making
Continued…
Hardness and Friability
Hardness
• Hardness is the force required to break a tablet in a
diametric compression test.
• Sometimes it is also referred to as the ‘crushing strength’.
Pharmaceutical importance:
• Tablets require a certain amount of hardness and resistance
to friability to withstand mechanical shocks of handling in
manufacture, packaging, shipping and in the hands of the
consumer.
• Adequate tablet hardness and resistance to friability are
necessary requisites for consumer acceptance.
• Excessive hardness can affect tablet disintegration , and
perhaps more significantly, the drug dissolution .
This is especially important for drug products that possess
real or potential bioavailability problems or may show altered
dissolution profiles as function of the compressive force.
Continued…
Process variables affecting tablet hardness:
• Compression force: At a constant die fill, compression force
hardness.
• Die fill: At a constant compression force, die fill hardness
• Time elapsed after compression: Tablets are harder several
hours after compression than they are immediately after
compression.
• Lubricants: concentration or mixing time hardness
• Tablet size: size hardness
• Punch shape: For a given tool, flat bevelled tool produce a
tablet harder than a deep cup tool.
Measurement:
• By diametric compression test:
The tablet is placed between two anvils, force is applied to
the anvils, and the crushing strength that just causes the
tablet to break is recorded.
• Devices used:
a) Monsanto tester
b) Strong-Cobb tester
c) Pfizer tester
d) Erweka tester
Continued…
Erweka Tester
Monsanto Tester
Pfizer Tester
Schleuniger Tester
Strong-Cobb Tester
Assignment: The operation and merits/
demerits (if any) of different hardness
Continued…
Friability:
Definition and Pharmaceutical Importance:
• Tablet hardness is not an absolute indicator of a tablet’s strength
because some formulations, when compressed into very hard
tablets, tend to “cap” on attrition (losing their crown portions).
• Friability is a complementary measure of tablet’s strength that
measures a tablet’s tendency to powder, chip and cap/fragment
when handled.
• Firable tablets lack elegance and consumer acceptance, and can
produce an excess of dust during coating and packaging.
• Fribility can also produce higher weight variation or content
uniformity.
Measurement:
• A set of preweighed tablets are subjected to
combined effects of abrasion and shock in a
plastic chamber.
• The chamber is revolved 100 times (4 min @
25 rpm) and then the tablets are dusted and
reweighed.
• For conventional compressed tablets, a
weight loss of < 0.5-1.0% is considered Roche Friabilator
acceptable.
Continued…
Conditions giving high friability
• Some chewable and most effervescent tablets (special
stack packaging is required)
• Use of concave (specially deep concave) punches
specially punches in poor condition or worn at surface
edges (cause whiskering)
• Use of very dry granulation with only fractional % of
moisture (More friable than granulation containing 2-4%
moisture)
Capping on Friability Testing
Should not be considered for commercial use
( regardless of % loss)
Rough Handling Test
• Can give an indication of how well a tablet will hold up
in its specified package and shipping container during
shipment.
• Usually include a vibration test, a drop test, and an
inclined plane impact test.
Continued…
DRUG CONTENT & RELEASE
• Evaluation of the drug content of a tablet and its ability to
release the drug is necessary to ascertain its potential for
efficacy.
Weight Variation and Uniformity of Content
• Four tests are routinely performed to evaluate drug content
of a tablet and tablet-to-tablet uniformity of content:
Determination of average weight
Weight variation test
Analysis of potency
Content uniformity test
Determination of average weight
• Average weight determination is routinely performed
throughout the compression process on composite samples
of tablets (usually 10).
Weight variation test
• Within the composite sample that has an acceptable average
weight, there could be tablets excessively overweight or
underweight.
Therefore, a weight variation test needs to be performed.
Continued…
• The USP weight variation test is run on a sample of 20
tablets. The tablets meet the test if no more than 2 tablets
are outside the permissible percentage limit and none
beyond 2 times the percentage limit.
• The weight variation test could reflect the uniformity of
content if all or essentially all (90-95%) of the tablet were
active ingredient (eg aspirin tab) or if the uniformity of the
drug distribution in the granulation were perfect.
• The test is clearly not sufficient to assure uniform potency of
tablets of low- or moderate-dose drugs.
Analysis of potency
• In potency determination, a composite sample of the tablets
is ground up, mixed and analysed to produce an average
potency.
• For highly potent, low-dose drugs (eg, digoxin) the
acceptable potency range is usually not less than 90% and
not more than 110% (ie, 10%) of the labelled amount.
• For most other larger-dose drugs the permitted official
potency range is not less than 95% and not more than 105%
(ie, 5%) of the labelled amount.
Continued…
Content Uniformity Test
• The average assay result could mask a wide variation in
potency which could be dangerous in case of low-dose
potent drugs with a narrow therapeutic window/range.
• Therefore, to assure uniform potency for tablets of low-dose
drugs, a content uniformity test is applied.
• In this test, 30 tablets are randomly selected for the sample,
and at least 10 of them are assayed individually.
Nine of the 10 tablets must contain not less than 85% or
more than 115% (ie, 15%) of the labelled content.
The 10th tablet may not contain less than 75% or more than
125% (ie, 25%) of the labelled content.
• If these conditions are not met, the remaining 20 tablets
must be assayed individually and none of them may fall
outside 85-115% (ie, 15%) range.
Factors causing nonuniformity of content
• Nonuniform distribution of the drug substance throughout
the powder mix or the granulation
• Segregation of the powder mixture or granulation
• Tablet weight variation.
Disintegration
Continued…
Significance:
• For most tablets, disintegration into smaller particles or granules is
the first important step for appearance of a drug into solution.
• Since the dissolution of a drug from the fragmented tablet controls
partially or completely the appearance of a drug into blood,
disintegration serves:
as a guide to formulator in the preparation of a optimum tablet
formula
as an in-process
Measurement of disintegration time (DT)
control test to ensure lot-to-lot uniformity.
• USP disintegration device is used for measuring the
DT of a Tablet.
• To be compliance with the USP standards, the
tablets must disintegrate and all particles must
pass through the 10-mesh screen in the time
specified.
If any residue remains, it must have a soft mass
with no probably firm core.
Disintegration time:
• Uncoated tablets: Minimum - 5 min (aspirin tablets);
Maximum -30 min (majority).
• Enteric coated tablets: No disintegration after 1
USP Disintegration
hour in simulated gastric fluid; then should Tester
disintegrate in 2 hours plus the time specified in the
Continued…
Dissolution
Significance:
• To ascertain that the drug is released from disintegrated
particles in solution at an appropriate rate.
• The rate of dissolution can directly indicate the efficacy of a
tablet product as well as the bioavailability differences
between formulations.
Assessment of Dissolution Rate
• In vivo bioavailability measurements
• In vitro dissolution tests
In vivo bioavailability measurement
Merit: Allows most direct assessment of drug release.
Demerits: Restricted for several reasons:
• length of time needed to plan, conduct and interpret the
study
• highly skilled personnel required for human studies
• low precision and high variability typical of the
measurements
• high cost of studies
• use of human subjects for “nonessential” research &
• necessary assumption that a perfect correlation exists
Continued…
In vitro dissolution studies
Scope:
• Because of the practical limitations of in vivo bioavailability
studies, in vitro dissolution studies are widely used as an
indirect measurement of bioavailability, especially in
preliminary assessment of formulation factors and
manufacturing methods that are likely to influence
bioavailability.
• However, it is critically important to correlate the in vitro
dissolution tests to in vivo bioavailability tests.
Objectives:
1)To ensure that the drug release is as close as possible to
100% &
2)To show that the release rate is
• uniform batch to batch &
• equal to the batches proven bioavailable and clinically
effective.
Methods: Continued…
USP-NF suggests two apparatuses for determining dissolution
rates:
Shaft
Shaft
Paddl
e
Baske Blad
t e
Tablet
Wire helix 375C
375C 100-mLFlask Tablet
Apparatus Apparatus
100-mLFlask 2
1
USP/NF monograph of a product specifies:
●test medium and volume, ●apparatus to be used, ●speed
(rpm) of
rotation, ●time limit of test, and ●assay procedure.
Continued…
Interpretation of Result:
• Dissolution testing and interpretation can be continued
through three stages if necessary.
• In stage 1 (S1), 6 tablets are tested and are acceptable if all
of the tablets are (Q + 5%) [Q monograph tolerance
• If the tablets fail S1, an additional 6 tablets are tested
limit].
(S2).
The tablets are acceptable if the average of the 12 tablets is
≥ Q and no unit is < (Q - 15%).
• If the tablets still fail the test, an additional 12 tablets
are tested (S3).
The tablets are acceptable if the average of all 24 tablets is ≥
Q and if not more than 2 tablets are < (Q - 15%).
• Industrial pharmacists routinely test their formulations for
dissolution. The results are plotted as concentration versus
time and values for t50%, t90% and the % dissolved in 30 min are
used as guides.
• A value for t90% of 30 min is often considered satisfactory and
Since: a common dissolution tolerance in the USP/NF is 75%
is an excellent
dissolved in 45 goal.
min.
Read Yourself
• Properties of Tablet
• In-Process Quality Control
Reference Books